Skip to main content
Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0750
-0.0080 (-9.64%)
May 19, 2025, 3:18 PM EDT

PVCT Revenue

Provectus Biopharmaceuticals had revenue of $278.63K in the quarter ending March 31, 2025, with 17.04% growth. This brings the company's revenue in the last twelve months to $657.70K, up 11.33% year-over-year. In the year 2024, Provectus Biopharmaceuticals had annual revenue of $617.14K with 10.66% growth.

Revenue (ttm)
657.70K
Revenue Growth
+11.33%
P/S Ratio
50.61
Revenue / Employee
109.62K
Employees
6
Market Cap
33.29M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024617.14K59.43K10.66%
Dec 31, 2023557.71K-431.33K-43.61%
Dec 31, 2022989.04K--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.73B
Veradigm 588.02M
Tian'an Technology Group 1.78M
Elite Pharmaceuticals 70.00M
Glass House Brands 215.62M
Northwest Biotherapeutics 1.47M
American Oncology Network 1.76B
BioStem Technologies 332.45M
Revenue Rankings

Provectus Biopharmaceuticals News

More News